← All Helix Acquisition CORP Ii filings

Helix Acquisition CORP Ii S-1 registration statements

Registration statements, filed ahead of a public offering, with the business description and financials a first-time investor sees.

HLXB
Helix Acquisition CORP Ii
S-1: BridgeBio Oncology Therapeutics Details Public Offering, Pipeline
BridgeBio Oncology Therapeutics, Inc. (BBOT) filed an S-1 registration statement detailing its recent SPAC merger, PIPE financing, and clinical-stage oncology pipeline targeting RAS and PI3K-driven cancers.
HLXB
Helix Acquisition CORP Ii
S-1MEF: Helix Acquisition Corp. II Files for Additional Share Registration
Helix Acquisition Corp. II files a registration statement to offer an additional 1,150,000 Class A ordinary shares.
HLXB
Helix Acquisition CORP Ii
S-1/A: Helix Acquisition Corp. II Seeks $150 Million in IPO to Target Healthcare Sector
Helix Acquisition Corp. II, a blank check company, aims to raise $150 million through an initial public offering to pursue a business combination within the healthcare industry.
HLXB
Helix Acquisition CORP Ii
S-1/A: Helix Acquisition Corp. II Eyes Healthcare Sector with $150 Million SPAC IPO
Helix Acquisition Corp. II, a blank check company, is set to launch a $150 million IPO targeting the healthcare industry.
HLXB
Helix Acquisition CORP Ii
S-1: Helix Acquisition Corp. II Files for $100 Million IPO Targeting Healthcare
Helix Acquisition Corp. II, a blank check company affiliated with Cormorant Asset Management, aims to raise $100 million in an initial public offering to pursue a business combination within the healthcare sector.